- Home
- CHEK vs MTNB Comparison
CHEK vs MTNB Comparison
Compare CHEK & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHEK
- MTNB
- Stock Information
- Founded
- CHEK 2004
- MTNB 2013
- Country
- CHEK Israel
- MTNB United States
- Employees
- CHEK N/A
- MTNB N/A
- Industry
- CHEK Medical Electronics
- MTNB Biotechnology: Pharmaceutical Preparations
- Sector
- CHEK Health Care
- MTNB Health Care
- Exchange
- CHEK Nasdaq
- MTNB Nasdaq
- Market Cap
- CHEK 4.4M
- MTNB 3.6M
- IPO Year
- CHEK 2015
- MTNB N/A
- Fundamental
- Price
- CHEK N/A
- MTNB $0.92
- Analyst Decision
- CHEK
- MTNB Hold
- Analyst Count
- CHEK 0
- MTNB 1
- Target Price
- CHEK N/A
- MTNB N/A
- AVG Volume (30 Days)
- CHEK 28.3K
- MTNB 370.4K
- Earning Date
- CHEK 08-14-2025
- MTNB 08-13-2025
- Dividend Yield
- CHEK N/A
- MTNB N/A
- EPS Growth
- CHEK N/A
- MTNB N/A
- EPS
- CHEK N/A
- MTNB N/A
- Revenue
- CHEK N/A
- MTNB N/A
- Revenue This Year
- CHEK N/A
- MTNB N/A
- Revenue Next Year
- CHEK N/A
- MTNB N/A
- P/E Ratio
- CHEK N/A
- MTNB N/A
- Revenue Growth
- CHEK N/A
- MTNB N/A
- 52 Week Low
- CHEK $0.56
- MTNB $0.47
- 52 Week High
- CHEK $3.04
- MTNB $9.60
- Technical
- Relative Strength Index (RSI)
- CHEK 41.81
- MTNB 54.26
- Support Level
- CHEK $0.75
- MTNB $0.88
- Resistance Level
- CHEK $0.86
- MTNB $1.04
- Average True Range (ATR)
- CHEK 0.03
- MTNB 0.08
- MACD
- CHEK 0.00
- MTNB -0.01
- Stochastic Oscillator
- CHEK 19.59
- MTNB 23.74
About CHEK Check-Cap Ltd.
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.